{"name": "Viroblock",
 "permalink": "viroblock",
 "crunchbase_url": "http://www.crunchbase.com/company/viroblock",
 "homepage_url": "http://www.viroblock.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "enterprise",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": 11,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@viroblock.com",
 "phone_number": "41-22-884-83-46",
 "description": "A novel anti-viral technology",
 "created_at": "Tue Feb 14 11:33:12 UTC 2012",
 "updated_at": "Tue Feb 14 12:06:05 UTC 2012",
 "overview": "\u003Cp\u003EViroblock is a Swiss based company focused on developing a novel anti-viral technology that is both rapid acting and broad spectrum.  Applied to non-woven fabric, the technology is particularly suited for air filtration products.  In fact, previous work has shown Viroblock fabric to kill over 99% of H5N1 viruses when challenged in standardized aerobiology experiments.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0017/4197/174197v1-max-150x150.jpg"],
     [[246,
       95],
      "assets/images/resized/0017/4197/174197v1-max-250x250.jpg"],
     [[246,
       95],
      "assets/images/resized/0017/4197/174197v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jamie",
      "last_name": "Paterson",
      "permalink": "jamie-paterson",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Thierry",
      "last_name": "Pelet",
      "permalink": "thierry-pelet",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.6M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/viroblock-sa-series-c-36m/",
    "source_description": "Viroblock, SA: Series C $3.6M",
    "raised_amount": 3600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 2,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "StartAngels Network",
         "permalink": "startangels-network",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0017/4200/174200v1-max-150x150.jpg"],
             [[250,
               40],
              "assets/images/resized/0017/4200/174200v1-max-250x250.jpg"],
             [[423,
               68],
              "assets/images/resized/0017/4200/174200v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Chemin des Aulx 18",
    "address2": "",
    "zip_code": "1228",
    "city": "Geneva",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        139],
       "assets/images/resized/0017/4198/174198v1-max-150x150.jpg"],
      [[250,
        232],
       "assets/images/resized/0017/4198/174198v1-max-250x250.jpg"],
      [[450,
        419],
       "assets/images/resized/0017/4198/174198v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}